Niraj Shah currently serves as the Global Strategic Account Manager at EditCo Bio since March 2024, following the acquisition of Synthego's engineered cell solutions. Previously, Niraj held the same title at Synthego Corporation from May 2023 to March 2024, having also worked as an Account Specialist from May 2022 to December 2022, focusing on lead generation and strategies for CRISPR tools and cell engineering services. Prior experience includes a role at Merck Life Science from January 2019 to May 2022, serving as a Technical Applications and Inside Sales Specialist and a Technical Application Specialist, providing global technical service on custom DNA and RNA products. Niraj holds a PhD in Molecular Pharmacology from the University of Liverpool and a Master's degree in Molecular Medicine from the University of East Anglia, along with a Bachelor's degree in Biology from the University of Nottingham.
This person is not in any teams
This person is not in any offices